Androgen-Receptor: A New Drug Target In Breast Cancer
Main Category: Breast CancerAlso Included In: Cancer / Oncology
Article Date: 14 May 2009 - 6:00 PDT
| Patient / Public: | ![]() |
3.5 (2 votes) |
| Healthcare Prof: | ![]() |
2 (2 votes) |
New results may help scientists develop treatments for women with a type of breast cancer that currently does not respond to targeted therapies.
Some cancers (triple-negative tumors) generally do not respond to receptor-targeted treatments. In recent years, scientists have begun looking for new targets in these "triple-negative" cancers. One that has been identified is the androgen-receptor.
Source
European Society for Medical Oncology
Visit our breast cancer section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/150070.php>
APA
http://www.medicalnewstoday.com/releases/150070.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





